RLS rotigotine patch open-label extension „study“

2-year safety and efficacy of rotigotine transdermal patch – initial placebo -why not benserazide?- controlled trial, without control group.
34 pages pdf, free full text: Benserazide not even mentioned.
http://www.biomedcentral.com/content/pdf/1471-2377-10-86.pdf

Werbeanzeigen
%d Bloggern gefällt das: